Exact Mass: 1268.655335

Exact Mass Matches: 1268.655335

Found 23 metabolites which its exact mass value is equals to given mass value 1268.655335, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Goserelin

C59H84N18O14 (1268.6414083999998)

L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000970 - Antineoplastic Agents

Goserelin

(2S)-1-[(2S)-2-{[(2S)-2-{[(2R)-3-(tert-butoxy)-2-{[(2S)-2-{[(2S)-1,3-dihydroxy-2-{[(2S)-1-hydroxy-2-{[(2S)-1-hydroxy-2-({hydroxy[(2S)-5-hydroxy-3,4-dihydro-2H-pyrrol-2-yl]methylidene}amino)-3-(1H-imidazol-5-yl)propylidene]amino}-3-(1H-indol-3-yl)propylidene]amino}propylidene]amino}-1-hydroxy-3-(4-hydroxyphenyl)propylidene]amino}-1-hydroxypropylidene]amino}-1-hydroxy-4-methylpentylidene]amino}-5-carbamimidamidopentanoyl]-N-[(C-hydroxycarbonimidoyl)amino]pyrrolidine-2-carboximidate

C59H84N18O14 (1268.6414083999998)

Goserelin is a synthetic hormone. In men, it stops the production of the hormone testosterone, which may stimulate the growth of cancer cells. In women, goserelin decreases the production of the hormone estradiol (which may stimulate the growth of cancer cells) to levels similar to a postmenopausal state. When the medication is stopped, hormone levels return to normal. L - Antineoplastic and immunomodulating agents > L02 - Endocrine therapy > L02A - Hormones and related agents > L02AE - Gonadotropin releasing hormone analogues C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D000970 - Antineoplastic Agents

Thalictoside D

C60H100O28 (1268.6400800000001)

Actinomycin Z4

C62H84N12O17 (1268.6077094)

3-O-beta-D-glucopyranosyl (1?6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)[alpha-L-rhamnopyranosyl(1?2)]-beta-D-glucopyranosyl 16-deoxybarringtogenol C|3-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1->6)[alpha-L-rhamnopyranosyl(1->2)]-beta-D-glucopyranosyl-16-deoxy-barringtogenol C|xanifolia O54

3-O-beta-D-glucopyranosyl (1?6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1?6)[alpha-L-rhamnopyranosyl(1?2)]-beta-D-glucopyranosyl 16-deoxybarringtogenol C|3-O-beta-D-glucopyranosyl(1->6)-beta-D-glucopyranosyl-28-O-beta-D-glucopyranosyl(1->6)[alpha-L-rhamnopyranosyl(1->2)]-beta-D-glucopyranosyl-16-deoxy-barringtogenol C|xanifolia O54

C60H100O28 (1268.6400800000001)

Actinomycin X2

C62H84N12O17 (1268.6077094)

3beta,20S,29-trihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[alpha-L-rhamnopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

3beta,20S,29-trihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[alpha-L-rhamnopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

C60H100O28 (1268.6400800000001)

12beta-O-acetyl-20-O-benzoyltomentogenin 3-O-beta-D-glucopyranosyl-(1->4)-6-deoxy-3-O-methyl-beta-D-allopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranoside

12beta-O-acetyl-20-O-benzoyltomentogenin 3-O-beta-D-glucopyranosyl-(1->4)-6-deoxy-3-O-methyl-beta-D-allopyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranoside

C64H100O25 (1268.655335)

3-O-β-D-glucopyranosyl-(1?2)-β-D-glucopyranosyl-28-O-α-L-rhamnopyranosyl-(1?2)-[β-D-glucopyranosyl-(1?6)]-β-D-glucopyranosy-21β,22α-dihydroxyl-olean-12-ene

C60H100O28 (1268.6400800000001)

12-O-cinnamoylsarcostin 3-O-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-beta-D-oleandropyranosyl-(1->4)-beta-D-cymaropyranosyl-(1->4)-beta-D-cymaropyranoside

C63H96O26 (1268.6189516)

(S)-jalapinolic acid 11-O-alpha-L-rhamnopyranosyl-(1->3)-O-[2-O-trans-cinnamoyl-3-O-isobutanoyl-alpha-L-rhamnopyranosyl-(1->4)]-O-[2-O-(S)-2-methylbutyryl]-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3 ester|batatoside A

(S)-jalapinolic acid 11-O-alpha-L-rhamnopyranosyl-(1->3)-O-[2-O-trans-cinnamoyl-3-O-isobutanoyl-alpha-L-rhamnopyranosyl-(1->4)]-O-[2-O-(S)-2-methylbutyryl]-alpha-L-rhamnopyranosyl-(1->4)-O-alpha-L-rhamnopyranosyl-(1->2)-O-beta-D-fucopyranoside 1,3 ester|batatoside A

C64H100O25 (1268.655335)

(11S)-[[O-alpha-L-rhamnopyranosyl-(1- >3)-O-[(2-O-trans-cinnamoyl)-(4-O-isobutanoyl)-alpha-L-rhamnopyranosyl-(1- >4)]-O-2-O-(2S)-methylbutanoyl-alpha-L-rhamnopyranosyl-(1- >4)-O-alpha-L-rhamnopyranosyl-(1- >2)-beta-D-fucopyranosyl]oxy]-jalapinoic acid intramolecular 1,2-ester

(11S)-[[O-alpha-L-rhamnopyranosyl-(1- >3)-O-[(2-O-trans-cinnamoyl)-(4-O-isobutanoyl)-alpha-L-rhamnopyranosyl-(1- >4)]-O-2-O-(2S)-methylbutanoyl-alpha-L-rhamnopyranosyl-(1- >4)-O-alpha-L-rhamnopyranosyl-(1- >2)-beta-D-fucopyranosyl]oxy]-jalapinoic acid intramolecular 1,2-ester

C64H100O25 (1268.655335)

Actinomycin X2|isoactinomycin-X2|[B3-(4-oxo-L-proline)]-actinomycin-D

C62H84N12O17 (1268.6077094)

3beta,20S-dihydroxydammar-24-en-21-carboxylic acid 3-O-{[alpha-L-rhamnopyranosyl-(1-2)]-[beta-D-glucopyranosyl-(1-3)]-beta-D-glucopyranosyl}-21-O-[beta-D-glucopyranosyl-(1-2)]-beta-D-glucopyranoside

C60H100O28 (1268.6400800000001)

PIM3 30:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-2-tetradecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C57H105O28P (1268.652966)

Leuprolide acetate

(Des-Gly10,D-Leu6,Pro-NHEt9)-LHRH acetate salt

C61H88N16O14 (1268.6665588)

C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1910 - Gonadotropin-releasing Hormone Analog D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones D012102 - Reproductive Control Agents > D005299 - Fertility Agents D000970 - Antineoplastic Agents

actinomycin c

C63H88N12O16 (1268.6440928)

2-amino-9-N-[(3R,6S,7R,10S,16S)-10-butan-2-yl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

2-amino-9-N-[(3R,6S,7R,10S,16S)-10-butan-2-yl-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3-propan-2-yl-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-4,6-dimethyl-3-oxo-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

C63H88N12O16 (1268.6440928)

H-DL-Pyr-DL-His-DL-Trp-DL-Ser-DL-Tyr-DL-Ser(tBu)-DL-Leu-Arg-DL-Pro-NHNHCONH2

C59H84N18O14 (1268.6414083999998)

2-amino-4,6-dimethyl-3-oxo-9-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15,18-hexaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

2-amino-4,6-dimethyl-3-oxo-9-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15,18-hexaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]-1-N-[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide

C62H84N12O17 (1268.6077094)

Gp100 (25-33), human (TFA)

C54H83F3N16O16 (1268.6124754)

Gp100 (25-33), human TFA (Hgp100 (25-33) TFA) is the amino acids 25-33 fragment of the human melanoma antigen. It is a 9-amino acid (AA) epitope restricted by H-2Db and recognized by the T cells[1].

2-amino-n1-{11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14,16-pentaoxo-3h,6h,9h,10h,13h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-n9-{11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

2-amino-n1-{11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14,16-pentaoxo-3h,6h,9h,10h,13h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-n9-{11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl}-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

C62H84N12O17 (1268.6077094)

n9-[(6s,9r,10s,13s,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-n1-[(6s,9r,10s,13s,18as)-13-[(2s)-butan-2-yl]-11-hydroxy-6-isopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

n9-[(6s,9r,10s,13s,18as)-11-hydroxy-6,13-diisopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-n1-[(6s,9r,10s,13s,18as)-13-[(2s)-butan-2-yl]-11-hydroxy-6-isopropyl-2,5,9-trimethyl-1,4,7,14-tetraoxo-3h,6h,9h,10h,13h,16h,17h,18h,18ah-pyrrolo[2,1-i]1-oxa-4,7,10,13-tetraazacyclohexadecan-10-yl]-2-amino-4,6-dimethyl-3-oxophenoxazine-1,9-dicarboximidic acid

C63H88N12O16 (1268.6440928)